Study Assessing an Algorithm-based Strategy of Eculizumab Discontinuation in Children and Adults With aHUS

NCT02574403 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

58

Enrollment

OTHER

Sponsor class

Conditions

Atypical Hemolytic Uremic Syndrome

Interventions

DRUG: eculizumab

Sponsor

Nantes University Hospital